| Patents for C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122) |
|---|
| 11/11/2010 | WO2010128061A1 Novel isoquinoline derivatives |
| 11/11/2010 | CA2760339A1 Novel isoquinoline derivatives |
| 11/09/2010 | US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis |
| 11/04/2010 | WO2010127307A1 Antimicrobial agents |
| 11/04/2010 | CA2760526A1 Antimicrobial agents |
| 11/03/2010 | EP2244577A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 10/27/2010 | CN101870694A 8,8-disubstituted-13,13a-dihyrdroberberine derivative as well as pharmaceutical composition and application thereof |
| 10/21/2010 | WO2007094548A3 Berberrubine derivatives having antifungal activities |
| 10/14/2010 | US20100261710 HDAC Inhibitors |
| 10/07/2010 | US20100256698 Isoquinolinone Potassium Channel Inhibitors |
| 10/06/2010 | EP2236488A1 Materials, methods and uses for photochemical generation of acids and/or radical species |
| 09/30/2010 | WO2010108903A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds |
| 09/30/2010 | US20100249124 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds |
| 09/30/2010 | CA2754176A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds |
| 09/29/2010 | CN101130541B Method for extracting and separating matrine and oxymatrine from trialkyl phosphine oxide inverse micellar solution |
| 09/29/2010 | CN101084989B Method for preparing general flavone and total alkaloid of sophora flavescens simultaneously |
| 09/28/2010 | US7803943 Use of bridged nucleic acid fluorescent dyes, such as phenanthridinium dyes, cyanine dyes, or acridinium dyes each having an ammonium group and anion; bridging group can be -CH2-CONH-(CH2-CH2-O)x-(CH2)2-NHCO-CH2- ; low background fluorescence in the absence of nucleic acids; noncarcinogenic, stability |
| 09/28/2010 | US7803811 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 09/28/2010 | CA2382247C Azaindoles having serotonin receptor affinity |
| 09/15/2010 | CN101830897A Novel isoquinoline alkaloid derivatives and preparation method and application thereof |
| 09/07/2010 | US7790739 Tyrosine kinase inhibitors |
| 09/02/2010 | US20100222355 Quinolizidinone m1 receptor positive allosteric modulators |
| 09/02/2010 | US20100222340 SUBSTITUTED PYRIDO [1,2-a] ISOQUINOLINE DERIVATIVES |
| 09/01/2010 | EP2222673A1 Octahydroquinoli zines for antidiabetic treatment |
| 09/01/2010 | CN100999522B Preparation process of palmatine |
| 08/25/2010 | EP2220085A1 Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes |
| 08/25/2010 | CN101812061A Method for producing tetrahydroberineper from berberine hydrochloride |
| 08/18/2010 | CN101804054A Application, preparation and preparation method of synthetic palmatine |
| 08/18/2010 | CN101172975B Method of preparing five-alkaloid composition of corydalis saxicola bunting |
| 08/17/2010 | US7776880 glycine transport inhibitors such as trans-threo-2-chloro-N-[(octahydroindolizin-5-yl)phenylmethyl]-3-trifluoromethylbenzamide hydrochloride, used for the treatment of behavioral disorders associated with dementia, psychoses, in particular schizophrenia and side effect reduction induced by neuroleptics |
| 08/11/2010 | CN101798304A Method for separating and purifying phellodendrine monomer |
| 08/11/2010 | CN101037436B L-stepholidine (l-SPD) derivatives, preparation method and usage thereof |
| 08/04/2010 | EP2212322A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 08/03/2010 | US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators |
| 07/21/2010 | CN101369633B Pyran derivative |
| 07/07/2010 | CN101768160A Preparation method of sipeimine |
| 07/07/2010 | CN101768159A Method for synchronously separating tetrahydropalmatine and fumarine from fumitory |
| 07/06/2010 | CA2539814C Isoquinolinone potassium channel inhibitors |
| 07/01/2010 | WO2010075469A1 Corydaline derivatives useful for reducing lipid levels |
| 06/29/2010 | US7745628 Method for obtaining a pharmaceutically active compound, synthesis intermediates thereof and methods for obtaining them |
| 06/29/2010 | US7745459 Quinolizinone compound and use thereof as HIV integrase inhibitor |
| 06/24/2010 | WO2010026436A3 1,3, 4, 6, 7, 11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders |
| 06/23/2010 | CN101747405A Berberine glycyrrhizic acid enantiomer salt and preparation method and usage thereof |
| 06/23/2010 | CN101255158B 9-N-substituted berberine derivatives as well as preparation method and use as anti-cancer drugs |
| 06/17/2010 | WO2010044981A3 Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 06/16/2010 | CN101099286B Method and installation means for installing an electrical machine |
| 06/10/2010 | US20100145050 Orthogonally fixed compounds for electrooptical applications |
| 06/09/2010 | CN101724002A Double salt formed by inosine and matrine or oxymatrine and application thereof in field of medicaments |
| 06/09/2010 | CN101723990A Complex salt consisting of glucuronic acid or glucurolactone and kushenin or matrine and application thereof |
| 06/09/2010 | CN101723944A Compound formed from ferulic acid and matrine compound and purpose thereof |
| 06/08/2010 | US7732458 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal composition containing them |
| 06/03/2010 | US20100137350 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal compositon containing them |
| 06/02/2010 | CN101717398A Sophocarpine-series derivative as well as preparation method and purposes thereof |
| 05/27/2010 | US20100130480 Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 05/26/2010 | CN101104618B Long chain alkyl berberine salt derivative, synthetic method and use |
| 05/26/2010 | CN101058580B Method of extracting matrine by ultrasound wave method |
| 05/25/2010 | US7723352 Isoquinolinone potassium channel inhibitors |
| 05/06/2010 | WO2010028004A3 Substituted berbines and processes for their synthesis |
| 05/04/2010 | US7709642 Spirohydantoin compounds and methods for the modulation of chemokine receptor activity |
| 04/28/2010 | EP1907366B1 New imidazole derivatives, preparation method thereof and organic electronic device using the same |
| 04/22/2010 | WO2010044981A2 Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 04/22/2010 | US20100098634 Imaging Agents Useful for Identifying AD Pathology |
| 04/22/2010 | CA2736409A1 Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 04/21/2010 | EP2176226A1 Method for making tetrabenazine compounds |
| 04/21/2010 | CN101695518A Method for extracting total alkaloid of common fibraurea stems, separate fibriuretinin and jatrorrhizine |
| 04/13/2010 | US7696222 Indole derivatives as CRTH2 receptor antagonists |
| 04/08/2010 | US20100087475 Pharmaceutical compounds |
| 04/01/2010 | US20100081821 Berberine compounds and processes for the preparation of berberine compounds |
| 04/01/2010 | US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter |
| 03/31/2010 | EP2166854A1 Triazole derivatives for treating alzheimer's disease and related conditions |
| 03/24/2010 | CN100595200C Compound of dehydrogenated cavidine group and application in medication |
| 03/11/2010 | WO2010028004A2 Substituted berbines and processes for their synthesis |
| 03/10/2010 | CN101665491A Synthetic method of berberine 13-bit derivant and berberrubine 13-bit derivant |
| 03/04/2010 | WO2010022412A1 Octahydroquinolizines for antidiabetic treatment |
| 02/24/2010 | CN100591680C Dihydrotetrabenazines and pharmaceutical compositions containing same |
| 01/26/2010 | US7652141 Immunosuppressants, analgesics, antiinflammatory agents |
| 01/14/2010 | US20100009985 THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS |
| 01/06/2010 | CN101619062A Natural fibrauretine crystal and macroporous adsorbent resin preparation method thereof |
| 01/05/2010 | CA2465723C Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 12/30/2009 | CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 12/23/2009 | EP1720859B1 Chemokine receptor antagonists |
| 12/23/2009 | CN100572380C Berberine ion pair compound, preparing method and drug containing same |
| 12/09/2009 | EP2130820A1 Antipruritics |
| 12/09/2009 | CN101597287A Method for synthesizing fibrauretine and fibrauretine |
| 12/01/2009 | US7626032 4-Amino-3,3-dimethylpiperidine; reduced toxicity, and improved pharmacology and pharmacokinetics |
| 12/01/2009 | US7626025 Isolated from Indian ascidian Synoicum macroglossum by solvent extraction; chromatography; for treatment of diabetic disorders by providing inhibition of alpha (alpha)glucosidase |
| 11/24/2009 | CA2299465C Use of benzo[c]quinolizine derivatives as plant growth regulators |
| 11/11/2009 | EP1477186B1 Antipruritics |
| 11/05/2009 | WO2009104147A3 Azatricyclic antibiotic compounds |
| 11/05/2009 | US20090275606 Heterocyclic Compounds as MEK Inhibitors |
| 10/28/2009 | CN100554270C Method for preparing dehydrogenated cavidine, dehydrogenated apocavidine and combination |
| 10/27/2009 | US7608714 Production of dolasetron |
| 10/22/2009 | US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines |
| 10/15/2009 | US20090258899 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof |
| 10/15/2009 | US20090258881 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 10/14/2009 | EP1461337B1 Pyrido¬2,1-a isoquinoline derivatives as dpp-iv inhibitors |
| 10/06/2009 | CA2258924C Cftr channel activator compounds and pharmaceutical compositions containing same |
| 09/23/2009 | CN101537193A Vesicle monoamine transporter target bound drug and preparation method thereof |
| 09/22/2009 | US7592350 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 09/03/2009 | WO2009040754A3 Polymorphs of s-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,5h-benzo[i,j]quinolizine-2-carboxylic acid lysine salt |